Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 57 results:
[ Author] Title Type Year Filters: Author is Tziomalos, Konstantinos [Clear All Filters]
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?.
Expert Opin Ther Targets. 12(7), 809-20.
(2008). Prevalence of resistant hypertension in 1810 patients followed up in a specialized outpatient clinic and its association with the metabolic syndrome..
Blood Press. 22(5), 307-11.
(2013). Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus..
Nat Clin Pract Endocrinol Metab. 5(1), 16-7.
(2009). Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke..
Am J Hypertens. 28(6), 765-71.
(2015). Dyslipidemia as a risk factor for ischemic stroke..
Curr Top Med Chem. 9(14), 1291-7.
(2009). Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity..
Cerebrovasc Dis. 41(5-6), 226-32.
(2016). The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia..
Curr Pharm Des. 23(10), 1495-1499.
(2017). Lipid lowering agents and the endothelium: an update after 4 years..
Curr Vasc Pharmacol. 10(1), 33-41.
(2012). Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure..
Curr Pharm Des. 20(40), 6306-13.
(2014). Triglycerides and vascular risk: insights from epidemiological data and interventional studies..
Curr Drug Targets. 10(4), 320-7.
(2009). Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation..
J Thromb Thrombolysis. 41(2), 336-42.
(2016). Prognostic significance of major lipids in patients with acute ischemic stroke..
Metab Brain Dis. 32(2), 395-400.
(2017). Management of statin-intolerant high-risk patients..
Curr Vasc Pharmacol. 8(5), 632-7.
(2010). Endothelial function, arterial stiffness and lipid lowering drugs..
Expert Opin Ther Targets. 11(9), 1143-60.
(2007). Effect of prior treatment with different statins on stroke severity and functional outcome at discharge in patients with acute ischemic stroke..
Int J Stroke. 8(7), E49.
(2013). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Kidney function and estimated vascular risk in patients with primary dyslipidemia..
Open Cardiovasc Med J. 3, 57-68.
(2009). Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke..
Clin Exp Hypertens. 39(3), 246-250.
(2017). Stress hyperglycemia and acute ischemic stroke in-hospital outcome..
Metabolism. 67, 99-105.
(2017). Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases..
Open Cardiovasc Med J. 5, 85-9.
(2011). Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients..
J Clin Hypertens (Greenwich). 16(4), 309-12.
(2014). Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance..
Front Biosci (Landmark Ed). 14, 237-62.
(2009). Nonalcoholic fatty liver disease and statins..
Metabolism. 64(10), 1215-23.
(2015). Adherence to antihyperglycemic treatment: a work in progress..
Expert Opin Pharmacother. 17(12), 1579-80.
(2016). Liver iron content determination by magnetic resonance imaging..
World J Gastroenterol. 16(13), 1587-97.
(2010).